The abrupt suspension of U.S. funding has forced dozens of critical HIV research trials across Africa to grind to a halt, jeopardizing advancements toward a potential cure for one of the continent’s deadliest diseases. Patrick Arbuthnot, a leading researcher at South Africa’s University of the Witwatersrand (Wits), received a stark email in January—two words that […]